Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Infective Endocarditis Diagnosis and Management

Infective Endocarditis Diagnosis and Management is a research topic within Epidemiology. Science Explorer counts 42k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers covers the management, diagnosis, treatment, epidemiology, and prophylaxis of infective endocarditis. It includes discussions on surgical approaches, complications, bacteremia, and guidelines for the diagnosis and antibiotic treatment. The cluster also explores the association between Streptococcus gallolyticus infection and colorectal cancer.

  • Infective Endocarditis
  • Diagnosis
  • Treatment
  • Epidemiology
  • Prophylaxis
  • Surgery
  • Complications
  • Bacteremia
  • Endocarditis Guidelines
  • Streptococcus gallolyticus
Research works
42k
fractional, since 1950
In the world top 10%
4.2k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Infective Endocarditis Diagnosis and Management

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Infective Endocarditis Diagnosis and Management research?

By volume, the United States and China publish the most (2.4k and 605 works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.4k works
  2. 2 China 605 works
  3. 3 Japan 525 works
  4. 4 Italy 435 works
  5. 5 India 382 works
  6. 6 Germany 371 works
  7. 7 Spain 357 works
  8. 8 United Kingdom 314 works
  9. 9 France 276 works
  10. 10 Australia 223 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.9%China: 10.3%Japan: 8.9%Italy: 7.4%6 others listed: 32.6%41%largest
United States2,413 · 40.9%China605 · 10.3%Japan525 · 8.9%Italy435 · 7.4%6 others listed1,924 · 32.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Infective Endocarditis Diagnosis and Management research?

By volume in 2022-now, Mayo Clinic publishes the most Infective Endocarditis Diagnosis and Management research, followed by Cleveland Clinic and Harvard University.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 98 works
  2. 2 Cleveland ClinicUnited States 83 works
  3. 3 Harvard UniversityUnited States 61 works
  4. 4 Sichuan UniversityChina 42 works
  5. 5 All India Institute of Medical SciencesIndia 41 works
  6. 6 Mount Sinai Health SystemUnited States 31 works
  7. 7 New York Medical CollegeUnited States 30 works
  8. 8 University of CopenhagenDenmark 29 works
  9. 9 InsermFrance 29 works
  10. 10 Northwell HealthUnited States 28 works

Who are the leading researchers in Infective Endocarditis Diagnosis and Management?

The most-cited researchers publishing on Infective Endocarditis Diagnosis and Management include David Moher, Ali H. Mokdad and Emelia J. Benjamin.

  1. 1 David Moher Canada 898k citations
  2. 2 Ali H. Mokdad United States 429k citations
  3. 3 Emelia J. Benjamin United States 341k citations
  4. 4 Jun Wang China 340k citations
  5. 5 Stephan Windecker Switzerland 338k citations
  6. 6 Graeme J. Hankey Australia 316k citations
  7. 7 Gordon Henry Guyatt Canada 315k citations
  8. 8 Gregory Y.H. Lip United Kingdom 311k citations
  9. 9 Peter Jüni Switzerland 303k citations
  10. 10 Róbert Langer United States 303k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Infective Endocarditis Diagnosis and Management?

The most cited paper in Infective Endocarditis Diagnosis and Management is "2017 ESC/EACTS Guidelines for the management of valvular heart disease" (Helmut Baumgartner et al., 2017), with 6,341 citations. Next come "2021 ESC/EACTS Guidelines for the management of valvular heart disease" (5,679) and "Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management" (5,276).

Most cited papers
#PaperReleasedCitations
1 2017 ESC/EACTS Guidelines for the management of valvular heart disease Helmut Baumgartner et al. · European Heart Journal Open access128 authors 26 Aug 2017 6,341
2 2021 ESC/EACTS Guidelines for the management of valvular heart disease Alec Vahanian et al. · European Heart Journal Open access123 authors 11 Jun 2021 5,679
3 Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management Steven Y. C. Tong, Joshua Saul Davis, Emily M. Eichenberger et al. · Clinical Microbiology Reviews Open access 27 May 2015 5,276
4 2015 ESC Guidelines for the management of infective endocarditis Gilbert Habib et al. · European Heart Journal Open access119 authors 29 Aug 2015 5,046
5 Burden of valvular heart diseases: a population-based study Vuyisile Tlhopane Nkomo, Julius M. Gardin, Thomas N. Skelton et al. · The Lancet 22 Aug 2006 4,913
All 99 most cited papers, with filters and sorting

Where is Infective Endocarditis Diagnosis and Management research done?

The largest centres of Infective Endocarditis Diagnosis and Management research in 2022-now are Madrid (Spain), New York (United States), Tokyo (Japan) and London (United Kingdom).

Largest cities, 2022-now

  1. 1 MadridSpain 122 works
  2. 2 New YorkUnited States 114 works
  3. 3 TokyoJapan 111 works
  4. 4 LondonUnited Kingdom 111 works
  5. 5 ClevelandUnited States 103 works
  6. 6 BeijingChina 89 works
  7. 7 ParisFrance 81 works
  8. 8 RomeItaly 74 works
  9. 9 MilanItaly 63 works
  10. 10 BostonUnited States 60 works
See Infective Endocarditis Diagnosis and Management on the map

Where is the best place to study Infective Endocarditis Diagnosis and Management?

Among universities, judged by research, Sichuan University, University of Copenhagen and University of Lausanne score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 20.09%fractional works in this field (log) →share of work in the world top 10% →University of LausanneSichuan UniversityUniversity of Copenh…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sichuan UniversityChina 77.521.3%2.5×42 +40.3%
2University of CopenhagenDenmark 76.819.2%4.2×29 +44.2%
3University of LausanneSwitzerland 75.823.8%5.2×17 +47.5%
4Harvard UniversityUnited States 73.416.4%2.6×61 -19.4%
5Humanitas UniversityItaly 65.024.8%7.6×8 +46.3%
6Karolinska InstitutetSweden 64.120.8%3.4×14 +4.2%
7Columbia UniversityUnited States 63.416.9%3.1×25 +7.4%
8University of BernSwitzerland 62.823.2%4.2×17 -15.8%
9Università Cattolica del Sacro CuoreItaly 61.916.3%5.1×16 +95.1%
10Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 60.318.2%3.3×25 +56.9%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Infective Endocarditis Diagnosis and Management, country by country

Is Infective Endocarditis Diagnosis and Management research growing?

Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Infective Endocarditis Diagnosis and Management.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Infective Endocarditis Diagnosis and Management as a percentage of every work published that year, 0.036% in 2024.

still counting0.020%0.040%0.060%Infective Endocarditis Diagnosis and Management0.034% in 202519801990200020102020

Fractional works of Infective Endocarditis Diagnosis and Management over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Infective Endocarditis Diagnosis and Management9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Infective Endocarditis Diagnosis and Management. Posts are plain text and can be reported.